TAKE Solutions Ltd, a global services provider in Life Sciences and supply chain management, has announced its financial results for Q2 FY18 reporting strong Q2 revenue and profit figures of Rs 3,709 million.
The company has reported an 18.7 per cent year-on-year growth in profits, carrying forward its growth momentum.
Last quarter, the company announced the consolidation of its specialised life sciences brands Navitas (technology-led life sciences services provider across clinical, regulatory and safety), Ecron Acunova (CRO with clinical and BA/BE capabilities) and Intelent (big data analytics expert) as Navitas Life Sciences, an end-to-end provider of transformative services offering a full-service coverage of the pharma and biotech R&D market.
The successful integration of the complimentary, niche capabilities of our legacy brands as Navitas Life Sciences continues to register tremendously positive business impact as witnessed by our consistently strong performances and prestigious industry recognitions. We are in a very promising position to penetrate new markets and further capitalize on global opportunities as we move closer to achieving the growth target envisioned in our transformational scale-up initiative, said Srinivasan HR, Vice Chairman and Managing Director, TAKE Solutions.
In recognition of its internal processes, structure and governance best practices, TAKE was recently bestowed with the Golden Peacock Awards for ‘Excellence in Corporate Governance’ by the prestigious Institute of Directors at their international convention of global leaders at London.